StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30508% above fair value
$199.33+2.54 (+1.29%)

Close on Nov 19, 2026Market cap $79.58BP/E –Yield –

Moderna net income

Net income is the profit left for shareholders after every expense, interest and tax.

Moderna's net income for the twelve months ending Jun 30, 2026 was -$3.15B. For fiscal 2025 it was -$2.82B. The highest annual figure on record is $12.20B in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.82B–
FY2024Dec 31, 2024-$3.56B–
FY2023Dec 31, 2023-$4.71B-156.4%
FY2022Dec 31, 2022$8.36B-31.5%
FY2021Dec 31, 2021$12.20B–
FY2020Dec 31, 2020-$747.00M–
FY2019Dec 31, 2019-$514.00M–
FY2018Dec 31, 2018-$384.73M–
FY2017Dec 31, 2017-$255.92M–
FY2016Dec 31, 2016-$216.21M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$782.00M–
Q1 FY2026Mar 31, 2026-$1.34B–
Q4 FY2025Dec 31, 2025-$826.00M–
Q3 FY2025Sep 30, 2025-$200.00M-1638.5%
Q2 FY2025Jun 30, 2025-$825.00M–
Q1 FY2025Mar 31, 2025-$971.00M–
Q4 FY2024Dec 31, 2024-$1.12B-616.1%
Q3 FY2024Sep 30, 2024$13.00M–
Q2 FY2024Jun 30, 2024-$1.28B–
Q1 FY2024Mar 31, 2024-$1.18B-1587.3%
Q4 FY2023Dec 31, 2023$217.00M-85.2%
Q3 FY2023Sep 30, 2023-$3.63B-448.0%
Q2 FY2023Jun 30, 2023-$1.38B-162.8%
Q1 FY2023Mar 31, 2023$79.00M-97.8%
Q4 FY2022Dec 31, 2022$1.47B-69.9%
Q3 FY2022Sep 30, 2022$1.04B-68.7%
Q2 FY2022Jun 30, 2022$2.20B-21.0%
Q1 FY2022Mar 31, 2022$3.66B+199.5%
Q4 FY2021Dec 31, 2021$4.87B–
Q3 FY2021Sep 30, 2021$3.33B–
Q2 FY2021Jun 30, 2021$2.78B–
Q1 FY2021Mar 31, 2021$1.22B–
Q4 FY2020Dec 31, 2020-$273.00M–
Q3 FY2020Sep 30, 2020-$233.00M–
Q2 FY2020Jun 30, 2020-$117.00M–
Q1 FY2020Mar 31, 2020-$124.00M–
Q4 FY2019Dec 31, 2019-$123.27M–
Q3 FY2019Sep 30, 2019-$123.22M–
Q2 FY2019Jun 30, 2019-$134.94M–
Q1 FY2019Mar 31, 2019-$132.58M–
Q4 FY2018Dec 31, 2018-$141.43M–
Q3 FY2018Sep 30, 2018-$80.33M–
Q2 FY2018Jun 30, 2018-$90.60M–
Q1 FY2018Mar 31, 2018-$72.38M–

More Moderna figures

See a number that looks wrong?